HUE031237T2 - Az immunitás modulálására, oltóanyag hatékonyságának fokozására, krónikus FHV-1 fertõzéssel összefüggõ morbiditás csökkentésére és kötõhártya-gyulladás megelõzésére vagy kezelésére szolgáló készítmények és eljárások - Google Patents

Az immunitás modulálására, oltóanyag hatékonyságának fokozására, krónikus FHV-1 fertõzéssel összefüggõ morbiditás csökkentésére és kötõhártya-gyulladás megelõzésére vagy kezelésére szolgáló készítmények és eljárások Download PDF

Info

Publication number
HUE031237T2
HUE031237T2 HUE08754373A HUE08754373A HUE031237T2 HU E031237 T2 HUE031237 T2 HU E031237T2 HU E08754373 A HUE08754373 A HU E08754373A HU E08754373 A HUE08754373 A HU E08754373A HU E031237 T2 HUE031237 T2 HU E031237T2
Authority
HU
Hungary
Prior art keywords
composition
animal
compositions
fhv
probiotics
Prior art date
Application number
HUE08754373A
Other languages
English (en)
Inventor
Ruth Knorr
Christoph Cavadini
Jalil Benyacoub
Ebenezer Satyaraj
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of HUE031237T2 publication Critical patent/HUE031237T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Claims (2)

  1. As. »Biwuwsisis moiiiîiàlâsâi-s, oköaaysg hslékoByságáttsk fok«-íásá«n krónikus í'HV-í Bu-íoké-ssol iiss.isfüggó Bíííí-fehikás c-5ókkíí5UH<'r<; és k5k'jk;Ás'ty;s-gyiíPíB.1iH mvgvkisv.oifv vagy kossAésörs vso^gíMé kèsx8i**é«yek is ^járások f xaMd 8Imi i0-iypornók L Kéaskméoy, ámoly isBolmókss sé MCHvlB 184!.$' CBF&amp;S) grolgoBkos Γ /bívAví h^-oanTtr·: BskléslBéltásgéli, öi3óhkáféMk.fep BlIV-Ϊ HhiWM MPÄyg'gyol Mák msgMkikébéú vagy te»!ésé!>oo IMltó Síkékgggásra,: 2 .;: Aé; k ||éóygont pgöM! Msakföénv M öö ägoglMlBAik!: slkäliAagSsm, #so| ä bséáhsM* ál l au làgliésâgîgéag vágy sgs«á|;|agáSgiíB^
  2. 3, ΛΑ slöKö sglégpoálgfe borou;!) Ao ssésagi ksHAOo ·;«):· a<·: ou «;og!euaoiou alkalo-ai^aa, 3ho; u pî-oblôiikos. LfU&amp;'ufarasx bakiin;;;« 0 MsklgÄy így gnotpijhni '«ύοΚοΑ iêgalâbb înlmegy II)5 Ί0:ΐ kôléulskopâô ègység
HUE08754373A 2007-05-24 2008-05-13 Az immunitás modulálására, oltóanyag hatékonyságának fokozására, krónikus FHV-1 fertõzéssel összefüggõ morbiditás csökkentésére és kötõhártya-gyulladás megelõzésére vagy kezelésére szolgáló készítmények és eljárások HUE031237T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/805,813 US20070280964A1 (en) 2005-10-06 2007-05-24 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

Publications (1)

Publication Number Publication Date
HUE031237T2 true HUE031237T2 (hu) 2017-06-28

Family

ID=40130611

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE08754373A HUE031237T2 (hu) 2007-05-24 2008-05-13 Az immunitás modulálására, oltóanyag hatékonyságának fokozására, krónikus FHV-1 fertõzéssel összefüggõ morbiditás csökkentésére és kötõhártya-gyulladás megelõzésére vagy kezelésére szolgáló készítmények és eljárások

Country Status (14)

Country Link
US (1) US20070280964A1 (hu)
EP (1) EP2164333B1 (hu)
JP (1) JP5421902B2 (hu)
CN (1) CN101686690A (hu)
AU (1) AU2008262495B2 (hu)
BR (1) BRPI0812299A2 (hu)
CA (1) CA2685066C (hu)
ES (1) ES2605733T3 (hu)
HU (1) HUE031237T2 (hu)
MX (1) MX2009012694A (hu)
PL (1) PL2164333T3 (hu)
RU (1) RU2490020C2 (hu)
WO (1) WO2008153655A2 (hu)
ZA (1) ZA200909209B (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
ES2556800T3 (es) * 2008-06-24 2016-01-20 Nestec S.A. Composiciones aromatizantes de Maillard y procedimientos de fabricación de las mismas
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8691792B2 (en) * 2009-08-05 2014-04-08 Nestec Sa Methods and compositions for improving gastrointetinal health
RU2421192C1 (ru) * 2010-03-09 2011-06-20 Винера Гумаровна Нафикова Способ лечения хронического бактериального конъюнктивита
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
GB201520497D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
TWI724099B (zh) * 2016-01-28 2021-04-11 日商康貝股份有限公司 用於改善或預防疱疹病毒感染症之組合物
CN110870577A (zh) * 2018-08-29 2020-03-10 广州普维君健药业有限公司 运动人士用免疫调节组合物及其制备方法与应用
CN110643744B (zh) * 2019-11-19 2022-10-21 南京农业大学 一种同时检测三种猫易感病毒的定量检测方法及其引物探针组合
CN112921122A (zh) * 2021-03-26 2021-06-08 广西大学 猫常见病毒多重pcr快速检测试剂盒及其引物组
US12350300B2 (en) * 2021-10-08 2025-07-08 Iowa State University Research Foundation, Inc. Use of dopamine producing products to increase vaccine efficacy
CN115109718B (zh) * 2022-05-25 2023-09-12 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株屎肠球菌菌株及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183684C (en) * 1994-02-18 2008-07-15 Richard D. Hansen Inoculation of animals with dried, pelleted biological materials
IT1282586B1 (it) * 1996-02-08 1998-03-31 Chemical And Biolog Ind Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
US6117477A (en) * 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
KR100522273B1 (ko) * 1998-09-08 2005-10-18 소시에떼 데 프로듀이 네슬레 소시에떼아노님 애완 동물용 우유 기재 분말
DE60119515T2 (de) * 2000-05-25 2007-05-24 Société des Produits Nestlé S.A. Probiotica für verwendung als haustierfutter
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
BRPI0616866A8 (pt) * 2005-10-06 2018-07-31 Nestec Sa Enterococos probióticos para melhorar a imunidade

Also Published As

Publication number Publication date
JP2010528004A (ja) 2010-08-19
MX2009012694A (es) 2009-12-10
CA2685066A1 (en) 2008-12-18
CA2685066C (en) 2016-04-26
WO2008153655A2 (en) 2008-12-18
RU2009147759A (ru) 2011-06-27
EP2164333A4 (en) 2010-07-28
EP2164333A2 (en) 2010-03-24
US20070280964A1 (en) 2007-12-06
EP2164333B1 (en) 2016-10-26
PL2164333T3 (pl) 2017-05-31
RU2490020C2 (ru) 2013-08-20
WO2008153655A3 (en) 2009-12-30
AU2008262495A1 (en) 2008-12-18
ES2605733T3 (es) 2017-03-16
ZA200909209B (en) 2011-02-23
BRPI0812299A2 (pt) 2014-09-30
JP5421902B2 (ja) 2014-02-19
AU2008262495B2 (en) 2013-04-04
CN101686690A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
EP2164333B1 (en) Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis
CA2624964C (en) Probiotic enterococci for improved immunity
US20170014356A1 (en) Methods of enhancing immunity in a companion animal
US20130216521A1 (en) Dietary supplement for enhancing animal health
AU2016222791A1 (en) Methods of treating diarrhea and promoting intestinal health in non-human animals
Moghaddam et al. The effects of four types of specific probiotic on growth performance, liver enzymes and immune indices of juvenile Persian sturgeon (Acipenser persicus).
Algedawy et al. Effect of commercial probiotic and exogenous enzymes on the growth performance, immune response, and hemato-biochemical parameters of broiler chickens.
Trench The Effects of Probiotics on Growth and Metabolism in Ram Lambs
RAMESH EVALUATION OF LYSOZYME AS POTENTIAL FEED SUPPLEMENTS FOR GROWTH PERFORMANCE AND GUT DEVELOPMENT IN BROILER BIRDS
CN116600644A (zh) 微生物菌株和抗生素
EP2706848A1 (en) Methods and compositions for preserving lean body mass during weight loss
Khan et al. Effects of organic feed supplements on live performance, biochemical profile and immune response of broiler chicks
CA3192065A1 (en) Microbials and antibiotics
Khaliel et al. Immunogenicity Associated with use of Chitozinc in Competing of Vibrio Algenolyticus in Cultured Sea Bream (Sparus Aurata, L.)
Wójcik et al. Experimental immunology Defence mechanisms of the offspring of ewes fed a diet supplemented with yeast (Saccharomyces cerevisiae) during pregnancy and lactation